Baxter (BAX) Announces Presentation of Strong Data on REVACLEAR in Lower Drug Use During Hemodialysis

July 27, 2016 8:31 AM EDT Send to a Friend
As a leader in innovative dialysis membranes, Baxter International Inc. (NYSE: BAX) announced the results of a large, retrospective, observational ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login